Technical Writer
University of California - San Diego, California, United States, 92154Work at University of California
Overview
- Apply
Overview
Please ensure you read the below overview and requirements for this employment opportunity completely.This role is to be based with our team in San Diego, CA.Main Responsibilities of the Technical Writer include:
Writing and summarizing technical content in a timely and proficient mannerDistilling key research findings and synthesizing content generated by the Boxer Capital team into written work that is both detail-focused and engagingAttending and documenting meetings, conferences, and key opinion leader discussions in great technical detailAssisting with scientific and medical data collection and archivalMaintaining an understanding of current trends and being able to thoughtfully speak on the latest developments in the healthcare sectorWorking collaboratively across internal teamsThe anticipated pay range for this position is as follows: $90,000-$125,000The compensation for this position may include overtime and a discretionary year-end merit bonus based on performance. Boxer Capital is an equal opportunity employer.Job Requirements:
Degree (MS/MA or higher) in a life science field is required1-3 years professional experience in the medical, biotechnology, or pharmaceutical industry1-3 years of experience in technical writing and editing (graduate work qualifies)A passion for science and medicine with a strong desire to learn about the biotechnology investing industryAbility to work on multiple projects at one time and excellent prioritization skills to manage projects simultaneously under deadline pressureThe ability to work both independently and in teamsDetail-oriented and organized, with excellent analytical and communication skillsHow to Apply: Please email your resume and a brief writing sample to careers@boxercap.com with the subject line: “Technical Writer”.Boxer Capital, LLC, is a private biotechnology investment fund based in San Diego, California that invents and invests in new therapeutics across multiple indications to create value through improved patient care and outcomes. Founded in 2005, Boxer Capital invests in private and public companies representing the entire drug development lifecycle - from early-stage pre-clinical discovery assets to late-stage clinical and commercial stage companies. Through disciplined analysis, our research and investment team identify opportunities to invest throughout the business life-cycle - from long-term positions with mature biotechnology companies that have strong leadership and high growth potential, to building new biotechnology companies from the ground up.
#J-18808-Ljbffr